• The Role Of Prior Breast Cancer Diagnosis In Articulating Expectations For Reconstructed Breast Appearance

    Nov 1, 2014, 00:00

  • Adaptive Video Games can Assess and Enhance Cognitive Health

    Nov 1, 2014, 00:00

  • Prescribing Pattern of Antibiotics In Neonates in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Which Metric To Choose For Indirect Comparison Of Treatments When Multiple Comparisons Are Feasible- Lubiprostone Verse Prucalopride In Chronic Constipation

    Nov 1, 2014, 00:00

  • Self Reported Health Care Resource Use and Indirect Economic Burden of Opioid Induced Constipation (Oic)

    Nov 1, 2014, 00:00

  • Indirect Comparison of Exacerbation Frequency Between Aclidinium and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00

  • Generic Penetration Within Top-10 Genericized Molecules – Greece Versus Major European Countries

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness AND Cost-Effectiveness of Audit and Feedback on Physician's Prescribing Indicators

    Nov 1, 2014, 00:00

  • The Effectiveness Of Carotid Artery Stenting Compared With Endarterectomy In Symptomatic Patients With Carotid Stenosis In Korean Multi-Center Setting

    Nov 1, 2014, 00:00

  • Measuring the Trend of Use of Targeted Therapy and Economic Evaluation of Gefitinib for Advanced Non-Small Cell Lung Cancer (Nsclc) in Singapore

    Nov 1, 2014, 00:00

  • The Intermediate Burden Of Diabetes Mellitus In Patients With Cardiovascular Disease (Cvd)- A Quality Adjusted Life Year (Qaly) -Analysis Based On Primary Longitudinal Data

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

    Nov 1, 2014, 00:00

  • Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis Trials

    Nov 1, 2014, 00:00

  • Brio- A European Prospective Observational Study to Assess the Burden of Disease and Treatment in Metastatic Breast Cancer (Mbc) Patients Treated with Oral Vinorelbine (Nvboral) or Intravenous Vinorelbine (Ivvino)

    Nov 1, 2014, 00:00

  • Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Cervical Lesions and Cervical Cancer in Slovakia

    Nov 1, 2014, 00:00

  • Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups

    Nov 1, 2014, 00:00

  • Clinical Characteristics Among Hypertension Patients with Diabetes in Shanghai, China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Evaluation of Brentuximab Vedotin for Refractory/Relapsed Hodgkin Lymphoma- A Comparative Analysis of the Results of Mexico and Venezuela

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors- Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Impact of Patient Programs On Adherence In Inflammation and Immunology- A Global Systematic Review and Meta-Analysis of Published Evidence

    Nov 1, 2014, 00:00

  • Impact of Non-Consented Switch and Subsequent Switch in Asthma Medication- Qualitative Study of Patient Perspective in the UK

    Nov 1, 2014, 00:00

  • Proposed Checklist for Non-Statisticians To Assess the Quality of A Network Meta-Analysis in the Context of A Nice Submission

    Nov 1, 2014, 00:00

  • Sources of Information and Pharmacists' Knowledge Regarding Rare Diseases and Orphan Drugs- Cross-Sectional Study In Serbia

    Nov 1, 2014, 00:00

  • Smoking Cessation Treatment Patterns and Characteristics of Patients with Copd Who are Attempting to Quit in Urban China

    Nov 1, 2014, 00:00

  • Importance Of Remission In Patients With Major Depressive Disorder In Korea For Improving Health-Related Quality Of Life And Economic Burden

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation Study On Preoperative Treatment Of Acromegaly With Somatostatin Analogues In Shanghai

    Nov 1, 2014, 00:00

  • Assessing the Translatability of the Term “Frustrated”

    Nov 1, 2014, 00:00

  • Results of A Decubitus Prevention and Wound Care Project

    Nov 1, 2014, 00:00

  • HBA1C Control Predictive Validity of Four Self-Reported Measures of Antidiabetes Medication Adherence

    Nov 1, 2014, 00:00

  • Activation of Endogenous Anti-Inflammatory Mediator Cyclic Amp Confers Protection in Murine Acute Pyelonephritis Induced by Uropathogenic E Coli

    Nov 1, 2014, 00:00

  • Instructions for Authors

    Nov 1, 2014, 00:00

  • A Cost Effectiveness Analysis of Everolimus Plus Exemestane Compared to Chemotherapy Agents for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom

    Nov 1, 2014, 00:00

  • Cost Effectiveness 0f Propofol Verses Thiopental in Icu Wards

    Nov 1, 2014, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Testing a Proposed Mcda Model for Orphan Drugs

    Nov 1, 2014, 00:00

  • The Valuation of EQ-5D-5L Health States in Korea

    Nov 1, 2014, 00:00

  • Patient Adherence Among Adolescents With Arterial Hypertension

    Nov 1, 2014, 00:00

  • The Use of Real World Data in the Decision-Making Process- An Example Using Blood Glucose Test Strip Use In Patients With Type 2 Diabetes In Ireland

    Nov 1, 2014, 00:00

  • The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands

    Nov 1, 2014, 00:00

  • Health Insurance Cost of Anxiety in Hungary- A Cost of Illness Study

    Nov 1, 2014, 00:00

  • From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

    Nov 1, 2014, 00:00

  • Economic Burden of Disease in France In 2012- A Top-Down Allocation of Health Care Expenditure by Disease Based on the French Health insurance Database (SNIIRAM)

    Nov 1, 2014, 00:00

  • What Drives Unemployment of HIV-Infected Patients in Germany?

    Nov 1, 2014, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00

  • Assessment of Validity of An Indicator Module In Identification of adverse Drug Events in Patients of Medicine Department

    Nov 1, 2014, 00:00

  • How The Implementation Of Drug Zero Markup Policy Will Affect Health Care Expenditure In Hospitals- Observation And Prediction Based On Zhejiang Model

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2014, 00:00

  • Characterizing Work Productivity Loss In Incident Rheumatoid Arthritis In Sweden

    Nov 1, 2014, 00:00

  • Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

    Nov 1, 2014, 00:00

  • Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

    Nov 1, 2014, 00:00

  • Level of Testing for Potential Medication-Related Co-Morbidities for Patients Taking Antipsychotics

    Nov 1, 2014, 00:00

  • The Evolution of International Reference Pricing- An Analysis of 39 Countries

    Nov 1, 2014, 00:00

  • Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug Use

    Nov 1, 2014, 00:00

  • Sharing of Information Across Studies to Inform Choice of Functional Form When Conducting Parametric Survival Analysis

    Nov 1, 2014, 00:00

  • Daily Dose and Costs Associated With Maintenance Therapy of Topical Testosterone Agents Among Hypogonadal Men

    Nov 1, 2014, 00:00

  • Key Cost Drivers Of Type 2 Diabetes Mellitus- an International Literature Review

    Nov 1, 2014, 00:00

  • Xpert Mtb/Rif Assay for Rapid Diagnosis in Patients with Suspected Tuberculosis in Hong Kong - a Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness of Counter Matching for Improving the Efficiency of the Nested Case-Control Design in Observational Studies

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Ldl-P-Guided Statin Therapy

    Nov 1, 2014, 00:00

  • Patients' Priorities in the Treatment of Neuroendocrine Tumors- An Analytic Hierarchy Process

    Nov 1, 2014, 00:00

  • The Cost Of Increasing Physical Activity And Decreasing Body Mass Index For Mid-Life African Women

    Nov 1, 2014, 00:00

  • Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the United Kingdom and the United States

    Nov 1, 2014, 00:00

  • Hydroxyethyl Starch And Hospitalized Mortality In Icu Patients With Diabetes- Database Study From A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00

  • Direct and Indirect Costs Associated With Increasing Body Mass Index (Bmi) In the Eu5

    Nov 1, 2014, 00:00

  • Economic Burden of Burn Injuries in the Netherlands

    Nov 1, 2014, 00:00

  • An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan

    Nov 1, 2014, 00:00

  • Health State Utility Valuation in Radio-Iodine Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, Italy

    Nov 1, 2014, 00:00

  • Increased Bone Mineral Density (Bmd) In Postmenopausal Women With Osteoporosis (Op) Receiving Two Denosumab Injections In Routine Clinical Practice In Bulgaria

    Nov 1, 2014, 00:00

  • A Gender Medicine Post-Hoc Analysis- Background and Methods of the Metagem Project

    Nov 1, 2014, 00:00

  • Psychometric Validation of the Newly Developed Phenylketonuria– Quality of Life (Pku-Qol) Questionnaires Assessing the Impact of Phenylketonuria and Its Treatment On Patients' Quality of Life

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Percent Free Psa for Prostate Cancer Detection in Chinese Men with a Total Psa of 4.0-10.0 Ng/Ml

    Nov 1, 2014, 00:00

  • The Economic Burden and their Predictors in Preschool Children with Dental Caries in Urban Beijing

    Nov 1, 2014, 00:00

  • Reasons for Treatment Discontinuation of Biologics – Development and Validation of A Questionnaire

    Nov 1, 2014, 00:00

  • Evidence-Based Market Access Value Resour Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries

    Nov 1, 2014, 00:00

  • Trends in Physical and Occupational Therapy Utilziation in the Us And Western Europe

    Nov 1, 2014, 00:00

  • Price Control Of Out-Patient Cancer Drugs In Bulgaria, 2010-2011- Reference Based Pricing And Public Tenders Verse Reference Based Pricing Only

    Nov 1, 2014, 00:00

  • Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • Evaluating The Effect Of Immunotherapy In Advanced Non-Small- Cell Lung Cancer Patients Using Two Components Mixture Model

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Lidocaine 5% Medicated Plaster Verse Pregabalin and Amitriptyline for the Treatment of Post-Herpetic Neuralgia In the Netherlands

    Nov 1, 2014, 00:00

  • A Novel Broadly Applicable Risk Score for Predicting Mortality of Patients with Circulatory System Diseases within Hospitalization Duration

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Para-Aortic Lymphadenectomy Before Chemoradiotherapy in Locally Advanced Cervical Cancer

    Nov 1, 2014, 00:00

  • Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • How Successful Have Pediatric Investigation Plans Been In Stimulating Research For Pediatric Cancers?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Dolutegravir for HIV Patients in Slovenia

    Nov 1, 2014, 00:00

  • The Performance- Volume Limit Decreased the DRG Based Acute Care Hospital Financing in hungary

    Nov 1, 2014, 00:00

  • Examining The Role Of Insulin Pen Devices In Acute Care Settings- A Review And Analysis of Health Resource Utilization

    Nov 1, 2014, 00:00

  • Relative Efficacy And Safety of Ustekinumab Compared to Anti-TNF-Alfa Therapies in Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Incidence of Drug Related Problem Admissions Emergency Department Visits in a Secondary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life Among Tuberculosis Patients in Pakistan- A Cross Sectional Study Using WHOQOL-BREF

    Nov 1, 2014, 00:00

  • Acute Respiratory Distress Syndrome- Treatment Pattern and Outcome Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In Portugal

    Nov 1, 2014, 00:00

  • Off-Label Use of Anticancer Drugs In South Korea

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Five New Antidepression Drugs A Network Meta Analysis

    Nov 1, 2014, 00:00

  • The Association Between The Nature And Timing Of Dental Visits And C-Reactive Protein Levels

    Nov 1, 2014, 00:00

  • Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Systematic Review of Societal Cost of Illness Evidence in Patients With Ankylosing Spondylitis

    Nov 1, 2014, 00:00

  • A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefit ...

    Nov 1, 2014, 00:00

  • Market Analysis in Regard to Biologically Active Supplements And Medicines in Armenia

    Nov 1, 2014, 00:00

  • Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan

    Nov 1, 2014, 00:00

  • Pre-Symptomatic Genetic Testing In Familial Amyloid Polyneuropathy- The Reproductive Options

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care System

    Nov 1, 2014, 00:00

  • Describing the Health Status of Schizophrenia Caregivers in the 5E.U

    Nov 1, 2014, 00:00

  • The Econimic Cost of Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00

  • Economic Impact of Genetic Diagnostic Test For Breast Cancer - Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2014, 00:00

  • Systematic Review and Mixed Treatment Comparison of Lithium or an Atypical Anti-Psychotic (AAP) used to Augment a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00

  • Systematic Literature Review and Mixed Treatment Comparison of Gxr Versus other Treatments in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2014, 00:00

  • Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In Brazil

    Nov 1, 2014, 00:00

  • Role of Corticosteroids Use in Ards- Comparison of Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Treatments for EGFR Mutation-Positive (M+) NSCLC Patients – A Network Meta-Analysis (NMA) by Mutation Type

    Nov 1, 2014, 00:00

  • Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute

    Nov 1, 2014, 00:00

  • Health and economic impact of combination therapy vs. Monotherapy for treatment of benign prostatic hyperplasia in hong kong

    Nov 1, 2014, 00:00

  • Burden of Drug Waste in Oncology- Optimization of Resource Use

    Nov 1, 2014, 00:00

  • Systematic Overview On Value-Of Information Analyses In Cancer Research

    Nov 1, 2014, 00:00

  • Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa

    Nov 1, 2014, 00:00

  • Co-Administration of Turmeric Potentiates Preventive Effect of Black Seeds in Metabolic Syndrome

    Nov 1, 2014, 00:00

  • Burden of Varicella in Asia-Pacific Countries- A Systematic Review and Critical Analysis

    Nov 1, 2014, 00:00

  • Challenges In Recruiting Patients For The Linguistic Validation Of Pro Instruments Developed For Rare Diseases- A Case Study With Alagille Syndrome

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls

    Nov 1, 2014, 00:00

  • Systemic Treatment of Metachronous Metastases After Curative Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Dapagliflozin In Combination With Insulin for the Treatment of Type 2 Diabetes Mellitus (T2dm) In Spain

    Nov 1, 2014, 00:00

  • Retrospective Analysis of the Economic Burden of Long-Term Care Facility Residents Diagnosed With Alzheimer's Disease in the United States

    Nov 1, 2014, 00:00

  • Non-Proliferative Diabetic Retinopathy- is It Cost-Effective to Treat Early?

    Nov 1, 2014, 00:00

  • Effect of Oral Nutritional Supplements On Hospital Outcomes in Patients Aged 65+ With Congestive Heart Failure

    Nov 1, 2014, 00:00

  • Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cell Transplanted Patients

    Nov 1, 2014, 00:00

  • The Pharmacoeconomics Review of 7-Valent Pneumococcal Conjugate Vaccination in Asian-Pacific Region

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

    Nov 1, 2014, 00:00

  • Cost of Illness Analysis of Duchenne Muscular Dystrophy In Italy

    Nov 1, 2014, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Models Due to Differing Patient Weights

    Nov 1, 2014, 00:00

  • Assessment of KAP Among Hospital Pharmacists

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece

    Nov 1, 2014, 00:00

  • Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

    Nov 1, 2014, 00:00

  • New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation Therapy

    Nov 1, 2014, 00:00

  • Direct Costs Of Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • A Review of The Utility Values Used in Published Cost-Effectiveness Analyses of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy in Patients With Diabetic Nephropathy

    Nov 1, 2014, 00:00

  • The Effectiveness and Safety of Febuxostat - An Experience in Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • Prescribing Pattern and Cost Analysis on (Dmard's) Disease Modifying Anti Rheumatoid Drugs in Rheumatoid Arthritis Patients of a Tertiary Care Teaching Hospital in South India – a Cross Sectional Study

    Nov 1, 2014, 00:00

  • Cost–Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Tia and Minor Stroke

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Four Chinese Patent Medicine in the Treatment of Angina Pectoris in China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

    Nov 1, 2014, 00:00

  • Epidemiological and Financial Burden of Preterm Labor Hospitalizations – An Analysis of German Claims Data

    Nov 1, 2014, 00:00

  • The Reimbursement of Expensive Drugs In Hospitals in Western European Countries

    Nov 1, 2014, 00:00

  • Third Party Participation in Early Benefit Assessment of Cancer Drugs in Germany

    Nov 1, 2014, 00:00

  • Pharmaceutical Market Access in Emerging Markets Through Innovative Patient Access Schemes

    Nov 1, 2014, 00:00

  • Buget Impact Analysis of Rituximab for Chronic Lymphocytic Leukemic- The Case of Brazilian Public Health

    Nov 1, 2014, 00:00

  • Comparative Efficacy And Tolerability Of Solifenacin 5mg Versus Oral Antimuscarinic Agents In Overactive Bladder (Oab)- A Systematic Literature Review (Slr) And Mixed Treatment Comparison (Mtc)

    Nov 1, 2014, 00:00

  • An Ecological Analysis on National Trends and Correlation Between Public Funding for Pneumococcal Vaccination and Pneumonia Disease Burden in the Japanese Elderly Population, 2005-2012

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis Of Clinical Option Scenarios For Metformin And Acarbose In Treatment Of Type 2 Diabetes- Based On Direct And Indirect Treatment Comparison Results

    Nov 1, 2014, 00:00

  • Epidemiology and Costs of Varicella and Herpes Zoster in Germany

    Nov 1, 2014, 00:00

  • Treatment Effect Heterogeneity in Clinical Trials- An Evaluation of 13 Large Clinical Trials Using Individual Patient Data

    Nov 1, 2014, 00:00

  • Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

    Nov 1, 2014, 00:00

  • A Review Of Patient Reported Outcomes (Pros) In Psoriasis According To The Food And Drug Administration (Fda) Pro Guidance Criteria

    Nov 1, 2014, 00:00

  • Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy

    Nov 1, 2014, 00:00

  • The Future of Education In HTA and Health Economics

    Nov 1, 2014, 00:00

  • Quality Of Life – A Rarely Acknowledged Key Category Within The Amnog Process in Germany

    Nov 1, 2014, 00:00

  • Comparing the Use of Patient-Level Data to An Average Patient Profile Within a Type 2 Diabetes Simulation Model

    Nov 1, 2014, 00:00

  • Evaluation of Adverse Drug Reaction (ADR) Monitoring and Reporting System in China

    Nov 1, 2014, 00:00

  • A Tutorial on Dimensionality Reduction in Large Claims Data Sets

    Nov 1, 2014, 00:00

  • Fda Cdx Category Medication Use During Pregnancy in the United States

    Nov 1, 2014, 00:00

  • Assessment of Lung Cancer Treatment by Disease Phase Using National Cancer Registry Data Linked with Treatment Pathway cost Data in Austria

    Nov 1, 2014, 00:00

  • Creating Patient Profile in Individual Simulations- A Comparison of Approaches

    Nov 1, 2014, 00:00

  • Effect of Health Education Program on Knowledge, Attitude, Practice and Health Related Quality of Life in Hepatitis-B Patients

    Nov 1, 2014, 00:00

  • Studies On Clinical Effectiveness Of Combined Classical Ayurvedic Formulations In Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Nurses' Perception Towards the Benefits of Pharmaceutical Care Services in Tertiary Health Care Settings Pakistan- A Qualitative Insight

    Nov 1, 2014, 00:00

  • Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment

    Nov 1, 2014, 00:00

  • Multicriteria Decision Analysis (MCDA) In HTA – Pilot Study in the Czech Republic

    Nov 1, 2014, 00:00

  • Investment Aspects of Generic Drug Policies in Countries With Severe Resource Constraints

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Coffee Consumption for Prevention of All-Cause Mortality in Germany

    Nov 1, 2014, 00:00

  • Health Economic Evaluation Comparing Iv Iron Ferric Carboxymaltose, Iron Sucrose and Blood Transfusion For Treatment of Patients with Iron Deficiency Anemia (Ida) in Singapore

    Nov 1, 2014, 00:00

  • The Association of Hosptial Type and Stroke Centre With Mortality, Length of Stay and Hospital Cost of Ischemic Stroke Patients in Alberta

    Nov 1, 2014, 00:00

  • An Analysis of the Health Technology Assessment Recommendation and Guidance on Use of Eq-5d-5l in Cost-Effectiveness Modeling

    Nov 1, 2014, 00:00

  • Are “Lively” and “Full of Pep” Similar Or Different Concepts? Challenges in Translating These Terms in Seven Languages

    Nov 1, 2014, 00:00

  • Task-Based Versus Case-Based Analysis of Time Outcomes in Multi-Country Time and Motion (TM) Studies- Methodological Considerations and Application

    Nov 1, 2014, 00:00

  • An Evaluation of the Performance of Eq-5d- A Review of Reviews of Psychometric Properties

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel and Capecitabine Plus Docetaxel in Metastatic Breast Cancer Patients in Egypt

    Nov 1, 2014, 00:00

  • Home Pharmacies- An Insight In Self-Medication Practice

    Nov 1, 2014, 00:00

  • Disease Burden of Multiple Myeloma in China

    Nov 1, 2014, 00:00

  • Rapid Relative Effectiveness Assessment of Pharmaceuticals- Transferability and Completeness of Information Derived From Global Value Dossiers To Complete A Eunethta Submission

    Nov 1, 2014, 00:00

  • The Analysis of Dental Care in Ukraine at the Regional Level

    Nov 1, 2014, 00:00

  • Real-World Data on the Epidemiology and Treatment of HR +, HER2-Advanced Breast Cancer in Postmenopausal Patients in Different Regions of Russia for Forming Markov Models of Managment of Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Umeclidinium Bromide Compared to Tiotropium Bromide for Symptomatic Patients with COPD in the UK

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Calcium Supplement in Reducing Preeclampsia-Related Maternal Mortality

    Nov 1, 2014, 00:00

  • An Analysis of the Key Value Drivers for HTA Assessments In Taiwan

    Nov 1, 2014, 00:00

  • Primary Treatments for Intermediate-Risk Prostate Cancer- a Cost-Effectiveness and Value-of-Information Analysis

    Nov 1, 2014, 00:00

  • Use of Medication Reminders in Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Mastectomy Due to Breast Cancer in Brazil- Geographic Distribution and Costs from the Public Health Care Perspective

    Nov 1, 2014, 00:00

  • The Value of Diagnostic Tests for Alzheimer's Disease- Discrete-Choice Experiment and Contingent-Valuation

    Nov 1, 2014, 00:00

  • Development of A Web-Based Tool To Elicit the Opinion of Regionally Dispersed Health Care Professionals Responsible for Medical Device Vigilance

    Nov 1, 2014, 00:00

  • Health Care Databases Applied to Antidepressants Use in Asia-Pacific

    Nov 1, 2014, 00:00

  • Mobile Phone Use in Patient Reported Outcomes– An Updated Literature Search

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Use of Gefitinib for the Treatment of Locally Advanced or Metastatic NSCLC

    Nov 1, 2014, 00:00

  • Construct a Cpoe Decision Supporting and Monitoring System to Decrease Pims Used in Hospitalized Elderly Patients

    Nov 1, 2014, 00:00

  • Use Of Computer Simulation To Generate Evidence To Aid Health Care Decision Making- An Example Using The Archimedes Model To Compare Rosuvastatin With Atorvastatin

    Nov 1, 2014, 00:00

  • Ophthalmology- Therapy Trends in Europe Based on Clinical Trial Registry Data

    Nov 1, 2014, 00:00

  • The Cost Effectiveness Analysis Of The Oral Anti-Viral Treatments Alternatives For The Chronic Hepatitis B In Turkey

    Nov 1, 2014, 00:00

  • Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy

    Nov 1, 2014, 00:00

  • Translation And Cultural Adaptation Difficulties Encountered During Linguistic Validation Of The Bristol Stool Scale

    Nov 1, 2014, 00:00

  • The "Venous Age"- A New Tool To Sensitize Patients To Their Venous Disease

    Nov 1, 2014, 00:00

  • Using Hormonal Contraception Reduce Unintended Pregnancy in China

    Nov 1, 2014, 00:00

  • Methods To Elicit Patient Preferences- A Case Study In Metastatic Breast Cancer

    Nov 1, 2014, 00:00

  • Readmittance To Hospital Within 6 Months After A Venous Thromboembolism Event- Prefer In Vte Registry

    Nov 1, 2014, 00:00

  • Cost-Minimization and Budget-Impact Analysis of Fixed-Dose Combination Inhalers in Treatment of Copd in Slovenia

    Nov 1, 2014, 00:00

  • Impact of Biologics Use on Depression and Anxiety Frequency and Health Care Resource Utilization In Psoriasis- An Analysis Using the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2014, 00:00

  • Pharmacological Basis for the Medicinal use of Almonds in Cardiovascular Disorders

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Of Ticagrelor Versus Generic Clopidogrel In The Treatment Of Patients With Acute Coronary Syndrome In Spain

    Nov 1, 2014, 00:00

  • Analysis of Volume and Structure of Oral Antidiabetic Drugs Consumption in Ukraine

    Nov 1, 2014, 00:00

  • Estimation of Economic Losses Resulting from Diseases Associated with Smoking in Mexican Insured and Uninsured Population

    Nov 1, 2014, 00:00

  • Treatment Patterns Among Heart Failure Patients Within 30 Days Post Diagnosis- Results From A Us Claims Database Analysis

    Nov 1, 2014, 00:00

  • Persistence in Health Expenditures by the Elderly in Taiwan- Predicting the Top 10% Users

    Nov 1, 2014, 00:00

  • Comparison Of Iqwig and G-BA Benefit Ratings in Oncology

    Nov 1, 2014, 00:00

  • Coverage or Efficacy- Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy?

    Nov 1, 2014, 00:00

  • Health Utility Of Acute Coronary Syndrome Patients From An Asian Population

    Nov 1, 2014, 00:00

  • Analysis of Cost-Effectiveness Assessments In France By The French National Authority For Health (Has)

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Medication use Among Young College Students During Menstrual Cycle

    Nov 1, 2014, 00:00

  • Association Between Baseline Socio-Demographic and Clinical Characteristics and Total Annual Cost of Patients Subjected to CRMDS Implantation

    Nov 1, 2014, 00:00

  • Layering Interventions for Type-2 Diabetes Prevention Using The Sphr Diabetes Model

    Nov 1, 2014, 00:00

  • Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries

    Nov 1, 2014, 00:00

  • Estimation of the Cost of Childhood Asthma in Turkey

    Nov 1, 2014, 00:00

  • Cost Analysis Of Pharmaceutical Service In Hospital- A Case Study In A Tertiary Hospital In Sichuan, China

    Nov 1, 2014, 00:00

  • Tecepoc II Study. How to Improve the Inhalation Techniques in Patient with Copd. The Influence of Preferences

    Nov 1, 2014, 00:00

  • A Budget Impact Analysis of Ustekinumab in the Management of Psoriatic Arthritis in Greece

    Nov 1, 2014, 00:00

  • An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK

    Nov 1, 2014, 00:00

  • Orphan Drug Policy- Approaches To Market Access In Multiple Countries

    Nov 1, 2014, 00:00

  • Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

    Nov 1, 2014, 00:00

  • Pain Incidence and Analgesic Consumption During Haemodialysis Sessions- Impact on Health-Related Quality Of Life

    Nov 1, 2014, 00:00

  • Sequential Combination of Chemotherapy With Egfr-Tki As The First-Line Treatment for Unselected Patients With Advanced Non-Small Cell Lung Cancer- Systematic Review of Randomized Controlled Trials

    Nov 1, 2014, 00:00

  • Value of Life and Cost of Pre-Mature Deaths With The Perspective of Productivity As Net Tax Revenue- A Comparison in France, Germany, Italy, Spain, United Kingdom

    Nov 1, 2014, 00:00

  • Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Multiple Anti-Osteoporotic Therapies for Secondary Fracture Prevention in Japan

    Nov 1, 2014, 00:00

  • Construct Validity of SF-6D Health State Utility Values in an Employed Population

    Nov 1, 2014, 00:00

  • Evaluation of Patient and Financial Outcomes Associated With Advanced Infertility Treatment Options

    Nov 1, 2014, 00:00

  • Budgetary Implications of Introducing Fluticasone Furoate/Vilanterol for Asthma in the UK

    Nov 1, 2014, 00:00

  • Study On The Direct Medical Cost of Malignant Neoplasms Inpatients With Urban Basic Health Insurance Scheme in China

    Nov 1, 2014, 00:00

  • Use Of Factor Analysis To Obtain Independent Health Performance Indicators

    Nov 1, 2014, 00:00

  • Amending the Guide to Methods of Technology Appraisal at Nice to Incorporate two New Value Elements- Burden of Illness And Wider Societal Impact

    Nov 1, 2014, 00:00

  • The Impact of Mutliple Sclerosis Severity on Quality of Life, Stress, Depression and Social Support Needs

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes (Pro) in Go/No-Go Decision Making in Drug Development

    Nov 1, 2014, 00:00

  • The Expanding Role Of The Patient Voice In Medical Decision Making In Asia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece

    Nov 1, 2014, 00:00

  • Comparison on the Concept of Market Access of China and Western Countries

    Nov 1, 2014, 00:00

  • The UK Cancer Drug Fund Scoring System and the Impact of the Incremental Cost Effectiveness Ratio on Funding Decisions

    Nov 1, 2014, 00:00

  • The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis- A Population-Based Study

    Nov 1, 2014, 00:00

  • Health Literacy and Health Care Utilization Among Adults with Osteoporosis

    Nov 1, 2014, 00:00

  • Hta In The Brazilian Health Care System and Potential Lessons Learned For Other Brics States

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Pazopanib Verse Sunitinib as First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC) iN Spain

    Nov 1, 2014, 00:00

  • Budget Impact Evaluation Of Treatment With A Low Protein Diet And Ketoanalogues Of Essential Aminoacids For Predialysis Patients In Russian Federation

    Nov 1, 2014, 00:00

  • A De-Novo Economic Model to Assess Clinical and Economic Consequences of Bronchiectasis

    Nov 1, 2014, 00:00

  • Renal Denervation With The Symplicity Catheter System For Treatment-Resistant Hypertension- A Budget Impact Analysis

    Nov 1, 2014, 00:00

  • The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2- A Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2014, 00:00

  • Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden

    Nov 1, 2014, 00:00

  • Association of Hypoglycemia With Different Oral Antidiabetic Treatments and Its Impact on Quality of Life and Disease Control In Patients With Type 2 Diabetes Mellitus (The Hypo Study)

    Nov 1, 2014, 00:00

  • Assessment of Outpatient Physiotherapy Services in Diseases of the Nervous System in Hungary

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • Cost Of Bleeding In Trauma Patients

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Saxagliptin Compared to Sitagliptin And Linagliptin As Triple Therapy In Combination With Metformin And A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • The Quality of Life of Patients Treated With Robotic Versus Traditional Surgery Results From An Italian Observational Multicenter Study

    Nov 1, 2014, 00:00

  • Modelling the Relationship between Sustained Virologic Response and Treatment Uptake Rates on Future Prevalence and Incidence of Hepatitis C in the UK

    Nov 1, 2014, 00:00

  • The Multicentric Castleman's Disease (Mcd) -Symptom Scale (Mcd-Ss)- Development and Validation of A Patient-Reported Outcome (Pro) Measure for An Ultra-Orphan Disease

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer

    Nov 1, 2014, 00:00

  • Price Negotiation For Pharmaceuticals in Germany- High Influence Of Eu Price Weighting Method

    Nov 1, 2014, 00:00

  • Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients- Results from a 1-Year European Outpatient Observational Study

    Nov 1, 2014, 00:00

  • COST EFFECTIVENESS ANALYSIS OF ANTIDEPRESSANTS ON BREAST CANCER PATIENTS- A MARKOV MODELING STUDY

    Nov 1, 2014, 00:00

  • The Cost of NSCLC Treatment in Three Countries- France, Germany and UK

    Nov 1, 2014, 00:00

  • Burden of Disease in Asian Countries and the use of Disability-Adjusted Life-Years and Quality-Adjusted Life-Years

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Dapagliflozin Compared To Dpp-4 Inhibitors as Triple Therapy In Combination With Metformin and A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Understanding the Rationale for Responses to a Time-Trade-Off Assessment and Willingness-To-Pay in Lung Cancer in Thailand

    Nov 1, 2014, 00:00

  • An Evaluation of Patient Satisfaction In Pafos, Cyprus With The “Europep” Instrument

    Nov 1, 2014, 00:00

  • Estimation of Stress Resistance of Medical Students in LVIV

    Nov 1, 2014, 00:00

  • Health Utility in Patients Following Cardiovascular Events

    Nov 1, 2014, 00:00

  • Economic Burden of Childhood Injury- A Review

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Sofosbuvir For Treatment Of Genotype2 Chronic Hepatitis C In Japan

    Nov 1, 2014, 00:00

  • Medical Costs of Cardiovascular Diseases in Taiwan

    Nov 1, 2014, 00:00

  • Current Annual Cost Calculation is the Best Predictor of Mortality at Three Years in COPD

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life for Patients with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Emergency Hormonal Contraception With Ulipristal Acetate Versus Levonorgestrel for Minors in France

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of Different Types of Labor for Singleton Pregnancy – Real Life Data

    Nov 1, 2014, 00:00

  • A Literature Review on Cost-Effectiveness of Treatments for Wet Age-Related Maculare Degeneration

    Nov 1, 2014, 00:00

  • What Is The Patients' Median Delay From The Referring Community Health Worker To Arrival in the Link Health Facility?

    Nov 1, 2014, 00:00

  • Prevalence of Cystic Fibrosis Among the U. S. National Medicaid Population

    Nov 1, 2014, 00:00

  • Maintenance Daily Dose of Venlafaxine and Duloxetine in the Monotherapy of Patients with Major Depressive Disorder Resistant to Selective-Serotonin-Reuptake-Inhibitors in Routine Clinical Practice in Spain

    Nov 1, 2014, 00:00

  • Access To Non Communicable Disease Medicines in India- A Comparative Analysis of State Level Public Procurement Data

    Nov 1, 2014, 00:00

  • Process Mapping to Capture Breast Cancer Patients' Journey in Greek Public Oncological Hospitals

    Nov 1, 2014, 00:00

  • Assessing Heterogeneity of Treatment Effect Using Real World Data

    Nov 1, 2014, 00:00

  • Transferability of Economic Evaluations To Central and Eastern Euroepan and Former Soviet Countries

    Nov 1, 2014, 00:00

  • Calibration And Statistical Modeling To Inform A Micro-Simulation Model For Early HTA

    Nov 1, 2014, 00:00

  • Modelling Survival in the Presence of Different Mechanisms of Action- Ipilimumab and Vemurafenib in Advanced Melanoma

    Nov 1, 2014, 00:00

  • Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain

    Nov 1, 2014, 00:00

  • Body Mass Index (BMI) as A Predictor of Outcome After Coronary Artery Bypass Grafting- An Asian Perspective

    Nov 1, 2014, 00:00

  • Understanding Trends In Ophthalmologist Patient Selection And Care Based On Patterns Of Billing

    Nov 1, 2014, 00:00

  • Treatment Patterns And Quality Of Life Of Patients With Non-Valvular Atrial Fibrillation- An Experience Of A Tertiary Health Care Centers (Treq-Af Study)

    Nov 1, 2014, 00:00

  • The Impact on Drug Price and Patiet Selection of National Essential Drug System- Evidence From Inpatient Records from Insurance Reimbursement Data

    Nov 1, 2014, 00:00

  • Can A Cvd Polypill Save Money In The ‘Real World'?

    Nov 1, 2014, 00:00

  • The Expanding Value Footprint of Oncology Treatments

    Nov 1, 2014, 00:00

  • Doctors' Failure in Observance of the COPD Management Guidelines- Case of the CZECH Republic

    Nov 1, 2014, 00:00

  • Regional Assessment of Severe Hypoglycemic Coma Events in Finland

    Nov 1, 2014, 00:00

  • Generating Health State Utility Values from Fact-Ovarian Data Collected in a Phase Ii Maintenance Study in Platinum Sensitive Recurrent Ovarian Cancer (Study 19)- A Comparison of Mapping Algorithms

    Nov 1, 2014, 00:00

  • Effect of Vaccination Age on Cost-Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer in China

    Nov 1, 2014, 00:00

  • Effect of Smoking Status on Health Care Costs In Patients With Type 2 Diabetes- A Retrospective Nested Case-Control Economic Study In Routine Clinical Practice

    Nov 1, 2014, 00:00

  • Patients' Preferences in Late Stage Treatment of Non-Small-Cell Lung Cancer- A Discrete-Choice Experiment

    Nov 1, 2014, 00:00

  • The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...

    Nov 1, 2014, 00:00

  • The Study of Satisfaction and Reasons for Acupuncture Therapy at Sirindhorn National Medical Rehabilitation Centre

    Nov 1, 2014, 00:00

  • Resource Utilization Pattern And Cost Of Tuberculosis Treatment In Penang, Malaysia

    Nov 1, 2014, 00:00

  • Acute Ischemic Stroke (Ais) Patient Management in French Stroke Units and Impact Estimation of Thrombolysis On Care Pathways and Associated Costs

    Nov 1, 2014, 00:00

  • The Determinants of Uptake and Diffusion of Innovative Health Technologies. An Empirical Analysis

    Nov 1, 2014, 00:00

  • Evaluation of Cost Effectiveness of OM-85 in China

    Nov 1, 2014, 00:00

  • Critical Appraisal Of Network Meta-Analyses Evaluating The Efficacy And Safety Of New Oral Anticoagulants In Atrial Fibrillation Stroke Prevention Trials

    Nov 1, 2014, 00:00

  • Acute Myeloid Leukemia and Myelodisplasic Syndrome Treated With Intensive Chemotherapy In France Based On National Hospital Databases (Pmsi)

    Nov 1, 2014, 00:00

  • Predictors of Working Motivation in Job Satisfaction Among Nurses in Cyprus

    Nov 1, 2014, 00:00

  • Prevalence and Associated Complication of Acute Kidney Injury Among Dengue Patients

    Nov 1, 2014, 00:00

  • A Payers Perspective to Pharmaceutical Market Access- Defining Market Access

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Chronic Lumbosciatic Syndrome in the Slovak Republic

    Nov 1, 2014, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (UMM) Patients Treated at the Antwerp University Hospital (UZA)

    Nov 1, 2014, 00:00

  • Economic Impact of Levalbuterol Versus Albuterol in Low-Income Population

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life in Migraine Without Aura Based on Attack Frequency- A time Trade-Off Study

    Nov 1, 2014, 00:00

  • Outpatient Treatment of Adolescents in Japan with Drugs for Attention Deficit Disorders

    Nov 1, 2014, 00:00

  • Are Prices of Patent-Protected Pharamceuticals in the Top 5 Eu Countries Converging?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Disease Management Programs For Cardiovascular Risk And Copd In The Netherlands

    Nov 1, 2014, 00:00

  • Quality of Life in Patients Undergoing Hemodialysis- A Vision of the Influence of Time

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis Tofacitinib Use in Rheumatoid Arthritis Treatment Scheme

    Nov 1, 2014, 00:00

  • Trends in Secondary Care Costs for Treatment of Head and Neck Cancer in England

    Nov 1, 2014, 00:00

  • High BMI and Belly fat Correlate with Prevalence of Hypertension And Diabetes- A Cross Sectional Study In Sedentary Urban Popultaion Of Delhi

    Nov 1, 2014, 00:00

  • Health-Related Quality Of Life Impact Of Triple Combinations Of Olmesartan Medoxomil, Amlodipine Besylate And Hydrochlorothiazide In Subjects With Hypertension

    Nov 1, 2014, 00:00

  • Adherence To Anticoagulant Therapy In Children Hospitalized for Pulmonary Embolism and Deep Vein Thrombosis

    Nov 1, 2014, 00:00

  • How do Organizational Arrangements of the Pharmaceutical Supply System Affect Availability to Essential Medicines in Rural China?

    Nov 1, 2014, 00:00

  • Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants

    Nov 1, 2014, 00:00

  • The Endometriosis Health Profile (Ehp) – A Case Study of Successful Epro Collaboration

    Nov 1, 2014, 00:00

  • Preliminary Assessment of the Cost of Treatment for Chronic Hepatitis C Virus Infections with Sofosbuvir and First Generation Antivirals Across Eight Countries

    Nov 1, 2014, 00:00

  • The Cost Burden of Community-Acquired Pneumonia in Russia in Adults of 50 and Older- A Regional Study and National Estimates

    Nov 1, 2014, 00:00

  • Quasi-Monte Carlo Simulation and Variance Reduction Techniques Substantially Reduce Computational Requirements of Patient-Level Simulation Models- an Application to a Discrete Event Simulation Model

    Nov 1, 2014, 00:00

  • Disability-Adjusted Life Years (Dalys) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (Tbe) in Slovenia

    Nov 1, 2014, 00:00

  • Coverage With Evidence Development Activities Around The World- An Environment Scan

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Crizotinib Treatment In Alk+ Non-Small-Cell Lung Cancer Patients In Thailand

    Nov 1, 2014, 00:00

  • The Economic Value of Vaccination- Why Prevention Is Wealth

    Nov 1, 2014, 00:00

  • Economic Assessment of Delaying Insulin Treatment Through The Use of Newer Anti-Diabetic Agents, Dapagliflozin (Forxiga®) And Exenatide (Bydureon®), Both As Add-On To Metformin; A Cost-Effectiveness Analysis From A Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • Epidemiology and Direct Health Care Costs of Diabetic Retinopathy- Results From a Population-Based Study

    Nov 1, 2014, 00:00

  • Value in the Making- Harvesting the Value of Complex Medical Innovations in Practice

    Nov 1, 2014, 00:00

  • Cost-Effectiveness And Budget Impact Analyses Of Risk Stratification Of Patients With Moderate Risk Of Cardiovascular Events Using Lp-Pla2 Testing

    Nov 1, 2014, 00:00

  • A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • Image-Guided Navigation Systems (IGNS) Improve Accuracy of Catheter Placement in Shunted Hydrocephalus Patients

    Nov 1, 2014, 00:00

  • The Benefits and Challenges of Submitting to the Nice Medical Technologies Evaluation Programme-Manufacturer Perceptions And Experiences

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the Original Drug Arglabin

    Nov 1, 2014, 00:00

  • Treatment Patterns and Health Care Costs in Patients with Schizophrenia Initiating with First- or Second-Generation Antipsychotic- Results from a Japanese Claims Database Analysis

    Nov 1, 2014, 00:00

  • Can Using a Resource Use Log in an Economic Evaluation Alongside a Randomised Controlled Trial Reduce the Amount of Recall Bias?

    Nov 1, 2014, 00:00

  • Survival Status in (Pharmaco) Epidemiological Studies can be Successfully Investigated Using Administrative Residential Registries

    Nov 1, 2014, 00:00

  • A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database

    Nov 1, 2014, 00:00

  • Quality Assessment of Controlled Trials Evaluating Chinese Herbal Medicine in Patients With Rheumatoid Arthritis- A Systematic Review

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Sacral Anterior Root Stimulation (SARS) Compared to Medical Treatment in Complete Spinal Cord Injured Patients with a Neurological Bladder

    Nov 1, 2014, 00:00

  • Financial Implications to Taiwan Health System from Changing the Dialysis Modality Mix

    Nov 1, 2014, 00:00

  • A Cost-Consequence Analysis of Human Papillomavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • An Analysis of Us Medicare Beneficiaries- Burden of Direct Medical Costs in Patients With Idiopathic Pulmonary Fibrosis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of Antiviral Pharmacotherapies For Treatment Of Chronic Hepatitis C Virus Infection In Russia

    Nov 1, 2014, 00:00

  • Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain

    Nov 1, 2014, 00:00

  • Economic Burden of Schizophrenia in China- Based on Medical Insurance Database from Guangzhou City

    Nov 1, 2014, 00:00

  • Burden of Lupus Nephritis (Ln) Among Patients Managed In Routine Clinical Practices In Europe (Eu)

    Nov 1, 2014, 00:00

  • Long-Term Cost-Effectiveness Of Biphasic Human Insulin 30 In People With Type 2 Diabetes With Inadequate Glycaemic Control On Oral Antidiabetic Drugs In China

    Nov 1, 2014, 00:00

  • Predictors of Adherence to Antidepressant Ýmedications in Saudi Arabia Ý

    Nov 1, 2014, 00:00

  • (Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy- Study Protocol of A Dutch Randomized Controlled Trial

    Nov 1, 2014, 00:00

  • The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer – A Systematic Review

    Nov 1, 2014, 00:00

  • A Systematic Review of Methods to Assess the Economic Impact of Air Pollution

    Nov 1, 2014, 00:00

  • Economic Burden of Pediatric Atopic Dermatitis in Asia-Pacific- A Review of the Literature

    Nov 1, 2014, 00:00

  • A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study

    Nov 1, 2014, 00:00

  • Using Data Envelopment Analysis (Dea) To Rank Gp's According To Their P4p Quality and Efficiency Scores

    Nov 1, 2014, 00:00

  • The Burden Of Chronic Urticaria In Europe- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Data Sources of Disease Epidemiology in German Drug Reimbursement Dossiers- Case Study Of Diabetes Mellitus Type II

    Nov 1, 2014, 00:00

  • Real World Data (Rwd) At T=4 in the Netherlands

    Nov 1, 2014, 00:00

  • Health Care Utilization and Costs of Breast Cancer in the Medicaid Program

    Nov 1, 2014, 00:00

  • Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?

    Nov 1, 2014, 00:00

  • Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

    Nov 1, 2014, 00:00

  • Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue- A Comparison In Argentina, Brazil And Mexico

    Nov 1, 2014, 00:00

  • Evaluation of Social Welfare Part of Hungarian Drug Provision System

    Nov 1, 2014, 00:00

  • Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

    Nov 1, 2014, 00:00

  • Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies

    Nov 1, 2014, 00:00

  • A Comparison of Additional Benefit Scores in Germany (Gba) and France (Has)

    Nov 1, 2014, 00:00

  • Baseline Patient Characteristics of A Prospective Observational Study to Evaluate the Care Map of Women With Postmenopausal Osteoporosis (Pmo) in Switzerland (Campos)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

    Nov 1, 2014, 00:00

  • Knowledge of Human Papillomavirus among University Students in Hungary

    Nov 1, 2014, 00:00

  • Evaluating the Economic Burden and Health Care Utilizations of U. S. Veteran Patients Diagnosed with Chronic Hepatitis C

    Nov 1, 2014, 00:00

  • Patient-Level Estimates of Diabetic Complications on Direct Medical Cost

    Nov 1, 2014, 00:00

  • Modification of Patient Reported Outcomes Measures of Compliance, Gastrointestinal Symptoms, Palatability and Treatment Satisfaction for Patients Needing Iron Chelation therapy

    Nov 1, 2014, 00:00

  • Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; The French Context

    Nov 1, 2014, 00:00

  • Economic Burden of Melanoma in Three European Countries- A Retrospective Observational Study

    Nov 1, 2014, 00:00

  • Critical Assessment of Cost-Sharing Schemes Using a Simple Modeling Approach

    Nov 1, 2014, 00:00

  • An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medication in the Elderly – Relevance and Economics of the 30 Top-Selling Priscus Agents in Germany

    Nov 1, 2014, 00:00

  • Epidemiology of Multiple Sclerosis in Latin America- Critical Analysis of the Literature

    Nov 1, 2014, 00:00

  • Study of Medication Adherence in Diabetes Mellitus Patients with Hypertension

    Nov 1, 2014, 00:00

  • Reimbursement Decisions in Oncology Drugs- An International Analysis

    Nov 1, 2014, 00:00

  • Assesment Of Serial Transverse Enteroplasty- Systematic Review

    Nov 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108 (current)
  • 109
  • 110
  • »